BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/30/2019 3:36:59 AM | Browse: 1302 | Download: 1980
Publication Name World Journal of Transplantation
Manuscript ID 47671
Country United States
ISSN 2220-3230 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Minireviews
Article Title Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders
Manuscript Source Unsolicited Manuscript
All Author List Tatyana Gavrilova
ORCID
Author(s) ORCID Number
Tatyana Gavrilova http://orcid.org/0000-0001-8428-5944
Funding Agency and Grant Number
Corresponding Author Tatyana Gavrilova, MD, Assistant Professor, Division of Allergy and Immunology, Montefiore Medical Center, 1525 Blondell Avenue, Bronx, NY 10461, United States. tgavrilo@montefiore.org
Key Words Primary immunodeficiency disorders; Hematopoietic stem cell transplant; Autoimmunity; Conditioning regimens; ;
Core Tip Primary immunodeficiency disorders (PID) result from inborn errors in immunity and hematopoietic cell transplant (HCT) still remains as the only curative option for many of these disorders. Severe combined immunodeficiency disorders belong to a subtype of PID that constitutes a medical emergency and requires HCT within weeks from the time of birth. Donor selection, conditioning regimen and outcomes of immune reconstitution vary greatly among these disorders. This manuscript reviews some of the unique elements of HCT in PID and evidence-based approaches to transplant in patients with these rare and complex disorders.
Publish Date 2019-07-30 03:36
Citation Gavrilova T. Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders. World J Transplant 2019; 9(3): 48-57
URL https://www.wjgnet.com/2220-3230/full/v9/i3/48.htm
DOI https://dx.doi.org/10.5500/wjt.v9.i3.48
Full Article (PDF) WJT-9-48.pdf
Full Article (Word) WJT-9-48.docx